In IBD patients, NF-κB signaling is often dysregulated resulting in inflammation and its activation is associated with the rapid, acute production of various proinflammatory mediators, such as IL-1β, and IL-6 [35]. This evidence concerns the gene NFKB1 and inflammatory bowel disease.